Indemn
PrivateLast Round
Pre Seed
Jan 31, 2024
Total Funding Raised
$1.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Indemn is an insurtech company that provides a generative AI-powered conversational platform for insurance carriers, MGAs, and brokers to streamline engagement and operations.
Sector
Enterprise Software
Verticals
InsurTech, NLP & Conversational AI, Workflow Automation, Low-Code/No-Code
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Indemn Comparables
Compare Indemn with similar companies based on industry and business-model similarity.
Indemn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 31, 2024 |
Key People
Founding team and executive leadership
Indemn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Everywhere Ventures | Pre Seed |
| AfterWork Ventures | Pre Seed |
| Markd | Pre Seed |
| InsurTech NY | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Jewelers Mutual Group acquired the EventGuard division.
- Feb 23, 2025
Added Event Guard, an Events Technology startup, as a customer.
Indemn Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Indemn's valuation, stock price, and market status.